Cocoanut Row Capital PartnersCocoanut Row↗
Cocoanut Row Capital Partners · Secondaries Research Briefing Vol. 05 · 2026
Pre-IPO Secondaries · U.S. Technology · Top-Ten Watchlist

The Post-Print Pipeline.

Three names from the April issue have printed — SpaceX, Cerebras, and X-Energy — and the frontier AI labs have both filed. The screen has been rerun in full: ten names positioned to price between Q3 2026 and Q3 2028, ranked by conviction.

Issued by
Cocoanut Row Capital Partners · Secondaries Desk
Issue Date
13 July 2026
Pages
17 · Confidential
Cocoanut Row Capital PartnersSection IMethodology
Section I / Screen & Universe

How the target list was rebuilt.

The same five filters as Vol. 04, applied fresh against a starting universe of ~140 venture-backed US technology companies with last-round valuations above $1B and active secondary marketplace coverage. Three April names graduated to the public market and exit the screen; every remaining and replacement name was re-tested as of the issue date.

01U.S. domicile · technology sectorHeadquarters in the United States. Sector-broad: software, AI, semiconductors, defense-tech, fintech infrastructure, consumer-tech.
02Liquidity catalyst within 3–24 monthsPublic S-1, confidential S-1, hired underwriters, or explicit management IPO commentary placing a print between October 2026 and July 2028.
03Upward valuation trajectoryLast primary mark up versus prior, AND/OR a secondary marketplace price (Forge, Hiive, Caplight, NPM) trending upward over trailing twelve months.
04Sector tailwindOperating exposure to a sub-sector with above-market near-term growth: frontier AI, AI infrastructure, defense autonomy, AI-native fintech, consumer-tech rebuild.
05Constructive PR (bonus)Net-positive press cycle in the trailing six months, supportive consensus among Tier-1 financial media, no material governance overhang.
Cocoanut Row Capital PartnersSection IIRanked List
Section II / The Ten

Ten names, ranked by conviction.

CompanySectorLast MarkΔ / Vol. 04*WindowStatus
01AnthropicSan Francisco, CAFrontier AI$965.0B+154%Q4 2026Conf. S-1 Filed
02OpenAISan Francisco, CAFrontier AI$852.0Bunch.Late '26 / '27Conf. S-1 Filed
03LambdaSan Jose, CAAI GPU Cloud$5.9Bunch.H2 2026Banks Hired
04DatabricksSan Francisco, CAEnterprise AI · Data~$170.7B†+27%2027Deferred · Pre-Filing
05Anduril IndustriesCosta Mesa, CADefense Autonomy$60.0B+22%†Late '26 / '27Pre-Filing
06RampNew York, NYFintech · AI Spend$44.0B+175%*Late '26 / '27IPO-Ready (Stated)
07MotiveSan Francisco, CAFleet AI · SaaSn/d—H2 2026S-1 Public
08DeelSan Francisco, CAGlobal HR · Payroll$17.3B+37%*2027Pre-Filing
09DiscordSan Francisco, CAConsumer · Comms~$8.5B−15%H2 '26 / '27Conf. S-1
10StravaSan Francisco, CAConsumer Health-Tech$2.2Bunch.H2 2026Conf. S-1

* Δ measured against the last mark cited in Vol. 04 (28 April 2026); for new entrants (Ramp, Deel), against the trailing-twelve-month primary mark. † Databricks: Forge Price valuation as of mid-June 2026, against the $134B Series L; a new primary round is reportedly in discussion at $165–175B. Anduril: Caplight-implied mark against the reported March 2026 round.

Cocoanut Row Capital PartnersIII · Target 01Anthropic
01

Anthropic

HQSan Francisco, CA
SectorFrontier AI
FilingConf. S-1 · Jun 1, 2026
Series H (May '26)$65B raised · $965B post
Series G (Feb '26)$380B post
Annualized Revenue~$47B (May '26)
Print WindowQ4 2026 (target)

The race to be the first public frontier lab is now Anthropic's to lose. A confidential S-1 filed June 1 — six days after a $65 billion Series H at $965 billion post — makes it the hardest catalyst on the board, on the cleanest enterprise AI revenue scale in the market.

Catalyst

Confidential S-1 submitted to the SEC on June 1, 2026. Wilson Sonsini retained since December 2025; Goldman, JPMorgan, and Morgan Stanley engaged. Q4 2026 listing remains the working target.

Trajectory

$65B (Mar '25) → $380B post (Feb '26) → $965B post (May '26). Annualized revenue ~$30B in April, ~$47B by the May company presentation. Management guides to break-even by 2028 — a rarity among the frontier labs.

PR & Demand

Strongly constructive: the filing beat OpenAI's by days and framed the entire AI listing cycle. Claude remains the dominant enterprise frontier model line. Watch cash burn disclosure once the S-1 goes public.

Secondary Angle

Demand still materially exceeds supply, but the issuer's transfer policy categorically voids unapproved SPV transfers — desk treats only issuer-approved direct transfers as executable. Confirm board approval in writing before pricing any block.

Cocoanut Row Capital PartnersIII · Target 02OpenAI
02

OpenAI

HQSan Francisco, CA
SectorFrontier AI
FilingConf. S-1 · Jun 2026
Mar '26 Round$122B raised · $852B post
IPO Talk~$1.0T
2026E Losses~$14B
Print WindowLate 2026 / 2027

The largest pre-IPO valuation ever assembled has now filed — but with a caveat the market heard clearly: "it may be a while." Whichever lab lists first sets the comp; as of this issue, that is more likely Anthropic.

Catalyst

Confidential IPO paperwork filed with the SEC in June 2026 per multiple reports, positioning a 2027 debut. The October 2025 PBC restructuring removed the structural blockers; IR leadership has been in place since late 2025.

Trajectory

$500B October '25 secondary → $852B post-money March '26 (SoftBank, Amazon, NVIDIA). Prediction markets put ~73% on a December 2026 print — but only single digits on anything before August.

PR & Demand

Mixed. Reported missed internal revenue targets, continuing Musk litigation, and CFO caution on public-company readiness sit against unmatched consumer scale. Profitability guided beyond 2030.

Secondary Angle

Transfer restrictions and governance complexity keep direct common transfers difficult. Most institutional flow remains structured forwards and LP-led continuation vehicles — triage by structure type before pricing.

Cocoanut Row Capital PartnersIII · Target 03Lambda
03

Lambda

HQSan Jose, CA
SectorAI GPU Cloud
FilingBanks Hired
Series E (Nov '25)$5.9B
Convert DeadlineIPO by ~Jan 2027
FY '25 Revenue$520M+
Print WindowH2 2026

Still the cleanest direct-secondary play in AI infrastructure — and the only name on the board with a contractual clock. The Mubadala-led convertible carries penalties if Lambda does not list within twelve months of the January close.

Catalyst

Morgan Stanley, JPMorgan, and Citi engaged; ~$350M in pre-IPO convertible notes closed in early 2026 with explicit list-by penalties. The structure effectively forces an H2 2026 filing decision.

Trajectory

$1.5B (2024) → $2.5B (Feb '25) → $5.9B (Nov '25). Multi-billion-dollar Microsoft and Nvidia agreements anchor the forecast; Nvidia sits on both sides of the trade as supplier and lessee.

PR & Demand

Constructive. CoreWeave remains the clean public comp and the print model is well understood. Build-phase operating losses persist — typical for the category, but they will headline the S-1 coverage.

Secondary Angle

Accessible direct-transfer mechanics relative to the AI mega-caps; Forge supply has stayed deep through H1. Continue to use as the executable complement to Anthropic and Databricks exposure.

Cocoanut Row Capital PartnersIII · Target 04Databricks
04

Databricks

HQSan Francisco, CA
SectorEnterprise AI · Data
FilingPre-Filing · Deferred
Series L (Dec '25)$134B
Round In Talks$165–175B
Forge (Jun 13)$242.04 · ~$170.7B
Run Rate · Growth$6.9B · +80% YoY
Print Window2027

Ghodsi said the quiet part on June 4: 2026 is "a terrible year to go public," and Databricks will raise privately instead — reportedly at $165–175 billion. The listing slips to 2027; the conviction does not.

Catalyst

Explicit 2026 deferral, explicit 2027 intent. A fresh primary round in discussion within a month of the statement functions as the pre-IPO bridge; JPMorgan-led $1.8B debt closed in January.

Trajectory

$62B → $100B → $134B across twelve months, with Forge now marking ~$170.7B. Run rate $5.4B in February (+65%) accelerating to $6.9B by June (+80%); AI products above a $1.4B run rate; NRR above 140%; FCF positive.

PR & Demand

Strongly positive. Lakebase, Agent Bricks, and the new Lakewatch SIEM widen the platform story. Snowflake still trades at a fraction of the mark — the rotation thesis holds if growth holds.

Secondary Angle

The widest, most predictable supply among the AI mega-caps: employee tenders plus RSU sellers. Best venue for size in AI infrastructure at IPO-tracking marks — now with an extra year of private runway to accumulate.

Cocoanut Row Capital PartnersIII · Target 05Anduril
05

Anduril Industries

HQCosta Mesa, CA
SectorDefense Autonomy
FilingPre-Filing
Reported Round$60B (Mar '26)
Caplight Implied~$73B
2026E Revenue$4.3B (vs $2.1B)
Print WindowLate 2026 / 2027

The trajectory is intact; the timing rhetoric has cooled. Luckey now says it is "bad to IPO in the middle of a hype cycle" — a line that reads as 2027 discipline, not retreat. Arsenal-1 production started this month, on schedule.

Catalyst

$4–8B round at $60B led by Thrive and a16z filling through mid-2026; management continues to state a public-company destination while declining to chase the current window. Arsenal-1 output began July 2026.

Trajectory

$14B (Aug '24) → $30.5B (Jun '25) → $60B (Mar '26), with Caplight implying ~$73B. Revenue roughly doubling annually: $1B → $2.1B → $4.3B forecast for 2026.

PR & Demand

Highly constructive amid sustained Pentagon spend (FY26 budget ~$856B). IVAS and CCA remain the headline programs; bipartisan support intact.

Secondary Angle

Direct supply remains thin and tightly held; the Caplight premium to the round signals persistent buy-side pressure. Size patiently — the extra private year favors disciplined accumulation over chasing marks.

Cocoanut Row Capital PartnersIII · Target 06Ramp
06

Ramp

HQNew York, NY
SectorFintech · AI Spend
FilingIPO-Ready (Stated)
Series F (Jun '26)$750M · $44B post
Mid-'25 Mark~$16B
Annualized Revenue$1.5B+ · FCF positive
Print WindowLate 2026 / 2027

New to the list, and the strongest fundamental profile of any entrant: a near-3× valuation step in twelve months, free cash flow positive, and a category rival removed from the board by Capital One's acquisition of Brex.

Catalyst

Management has told investors Ramp will be IPO-ready by year-end 2026, with public-company reporting infrastructure being built now. ICONIQ, GIC, and Ontario Teachers' anchoring the June round is a textbook pre-IPO register.

Trajectory

~$16B (mid-'25) → $32B (late '25) → $44B (Jun '26). Annualized revenue above $1.5B, purchase volume ~$200B annualized, TPV growth ~170% YoY in March across 70,000+ customers.

PR & Demand

Strongly positive: the AI spend-management pillar (token cost governance) gives Ramp the AI narrative fintech peers lack. Prediction markets still put modest odds on a pre-2027 filing — window discipline is warranted.

Secondary Angle

Round competition left allocation demand unfilled — a constructive setup for direct secondary bidders near the $44B mark. Cleaner transfer mechanics than the AI labs; confirm ROFR posture per block.

Cocoanut Row Capital PartnersIII · Target 07Motive
07

Motive

HQSan Francisco, CA
SectorFleet AI · SaaS
FilingS-1 Public · Dec 23, '25
ListingNYSE · "MTVE"
Revenue (9M '25)$327.3M · +22% YoY
Net Loss (9M '25)$138.5M
Print WindowH2 2026

The hardest catalyst below the mega-caps: a public S-1 on file since December, ticker reserved, syndicate seated — and no print. The question is not whether Motive lists, but at what mark after seven months in the queue.

Catalyst

Public S-1 filed December 23, 2025; JPMorgan, Citigroup, Barclays, and Jefferies leading. The offering had not priced as of the issue date — the SEC backlog and window congestion are the stated frictions.

Trajectory

Revenue growing +22% YoY at a ~$440M annualized pace; losses widening in absolute terms as the AI product suite scales. No recent primary mark — pricing discovery will happen in the book, not the private market.

PR & Demand

Quietly constructive; the fleet-AI framing (cameras, telematics, spend) reads as applied AI with real revenue. Samsara is the obvious public comp and trades at a full multiple.

Secondary Angle

Thin secondary float and a live registration limit pre-print entry. Best treated as an allocation exercise at pricing rather than a block trade — flag interest with the syndicate early.

Cocoanut Row Capital PartnersIII · Target 08Deel
08

Deel

HQSan Francisco, CA
SectorGlobal HR · Payroll
FilingPre-Filing
Last Round (Oct '25)$300M · $17.3B
ARR~$1.4B
Print Window2027

The steadiest of the HR-fintech cohort and the one with public statements of intent on record. At ~12× ARR against peers marked materially higher, Deel is the value entry in a category the market will re-rate on its first major print.

Catalyst

CEO commentary on record since early 2025 — "getting ready to go out, potentially next year or a bit later" — backed by a late-2025 round explicitly framed around IPO preparation. No banks publicly named yet.

Trajectory

$12.6B → $17.3B across 2025 rounds (+37%), on ~$1.4B of annual recurring revenue. Category consolidation (Brex to Capital One) tightens the comp set in Deel's favor.

PR & Demand

Net positive; the litigation cycle with Rippling has receded from headlines. Global payroll remains a structurally growing category with genuine cross-border moat.

Secondary Angle

Periodic employee tender flow provides entry points below primary marks. A softer catalyst than others on this list — size accordingly and re-screen on any underwriter mandate.

Cocoanut Row Capital PartnersIII · Target 09Discord
09

Discord

HQSan Francisco, CA
SectorConsumer · Comms
FilingConf. S-1 · Jan 6, '26
Forge (Jul 8)$31.31 · ~$8.5B
2021 Peak$15.0B
MAU · Revenue200M+ · ~$725M ('24)
Print WindowH2 2026 / 2027

Six months after filing: no price, no ticker, no date. The asymmetric setup from Vol. 04 has softened — the Forge mark has drifted below the April level — and Discord moves down the list rather than off it.

Catalyst

Confidential S-1 on file since January 6 with Goldman and JPMorgan leading. The original March target slipped through Q2; a second-half 2026 or 2027 debut is now the realistic range.

Trajectory

Marks recovered from the ~$7B trough but sit ~15% below the level cited in Vol. 04 and ~43% below the 2021 peak. The Reddit precedent — pricing below peak, popping on debut — remains the bull framing.

PR & Demand

Mixed. Non-gaming diversification (~54% of usage) is the pitch; monetization risk, a disclosed breach, and age-verification liabilities are the discount.

Secondary Angle

Ample supply, modest demand — buy-side pricing leverage persists. Suitable only for clients who underwrite an IPO mark below cost basis as an acceptable outcome. Still not a momentum trade.

Cocoanut Row Capital PartnersIII · Target 10Strava
10

Strava

HQSan Francisco, CA
SectorConsumer Health-Tech
FilingConf. S-1 · Feb 2, '26
May '25 Round$2.2B (Sequoia)
Lead UnderwriterGoldman Sachs
Users180M+ registered
Print WindowH2 2026

The spring window came and went, but the filing is confirmed by the company itself and the business is profitable — a small-ticket diversifier that costs little to hold on the list while the queue clears.

Catalyst

Company-confirmed confidential S-1 (February 2, 2026); Goldman leading, with an IPO-experienced CFO (Nextdoor, Block) seated since August 2025. Timing now reads H2 2026 as the SEC backlog works through.

Trajectory

Sequoia's May 2025 round priced above prior marks; profitable since 2021 per management. Modest but positive — the floor case among the ten.

PR & Demand

Net positive: premium-demographic brand strength, GLP-1 and connected-fitness tailwinds, ~50M monthly actives. Device-ecosystem reliance (Garmin, Apple) remains the structural risk.

Secondary Angle

Smaller ticket sizes and cleaner transfer mechanics than anything above it on the list. Best used for diversified pre-IPO baskets and for clients below institutional minimums.

Cocoanut Row Capital PartnersSection IVThe Scoreboard
Section IV / The April Cohort, Marked

Four names printed. The tape, to date.

Three of Vol. 04's ten — plus one bench name — reached the public market between the issues. Aftermarket levels are indicative as of late June 2026 and cited for desk calibration, not as executable quotes.

SpaceXSPCX · Jun 12
Largest IPO in history: $75B raised at a fixed $135. Opened above $2T market cap, touched $225.64 intraday June 16, then retraced on a $25B bond issue and index-flow volatility.
IPO Price$135.00
Late June~$153 · +13%
CerebrasCBRS · May
Priced at $185 on an upsized $5.6B raise; closed the first session up 68% above $311 before giving back ~10% the following day. The cleanest validation of the AI-hardware print model.
IPO Price$185.00
Day One+68%
X-EnergyXE · Apr 24
Upsized to $23 against a $16–19 range; ~$1.1B net proceeds. Trading slightly below issue by mid-June at a ~$6.2B market cap — the AI-power thesis priced fully at allocation.
IPO Price$23.00
Jun 19$21.56 · −6%
QuantinuumQNT · Jun 4
A Vol. 04 bench name (domicile question) that printed anyway: $1.68B raised at $60, valuing the company at ~$15.6B against a $10B 2025 private mark. Traded $64–68 on debut.
IPO Price$60.00
Day One$64–68
Cocoanut Row Capital PartnersSection VMonitor List
Section V / Honorable Mentions

On the bench — but not yet.

Stripe

$159B · Feb '26 tender

Still the most valuable private fintech, still without a catalyst. Executives remain evasive on timing and continue to favor tenders over a listing. Nothing in H1 changed the 3–24-month test.

Verdict · Catalyst absent

Kraken

$13.3B · Apr '26 round

Confidential S-1 on file since November, but the listing was paused in March and the April round marked the company down ~33% from its $20B peak. Fails the upward-trajectory filter until a higher mark prints.

Verdict · Trajectory wrong way

Figure AI

~$39B · Sep '25 Series C

The face of the humanoid cycle, with Nvidia, Microsoft, and OpenAI on the register — and no filing, no banks, and ample private runway. Watch for underwriter mandates; nothing to date.

Verdict · Catalyst absent

Polymarket

$15B · ICE-backed

Valuation trajectory remains constructive and the ICE relationship deepens the institutional case, but the consensus listing window still sits at 2027 or later. Re-screen as previously scheduled, Q1 2027.

Verdict · Re-screen Q1 2027
Cocoanut Row Capital PartnersSection VICross-Cutting Risks
Section VI / Cross-Cutting Risks

Four risks the desk is underwriting.

i.

Mega-cap absorption

SpaceX withdrew $75B of demand in a single week, and Anthropic and OpenAI could each exceed it. Index fast-tracking amplifies the flows. Smaller prints in the queue — Motive, Discord, Strava — face crowding-out risk on timing and pricing.

ii.

Window fatigue & slippage

Databricks deferred outright, Discord has slipped two quarters, Kraken paused, Revolut pushed to 2028. The pattern of H1 is that filings are not prints. Underwrite each name to its own clock, not to the market's enthusiasm.

iii.

AI concentration in the basket

Six of the ten names carry direct AI exposure, and the June Nasdaq drawdown (−7% in ten sessions) showed how correlated the cohort trades. Deliberate diversification — defense (Anduril), fintech (Ramp, Deel), consumer (Discord, Strava) — remains available inside the list.

iv.

Transfer restrictions

Anthropic's policy voids unapproved SPV transfers categorically; OpenAI flow remains dominated by structured forwards and continuation vehicles. Written issuer confirmation of an approved transfer path precedes any bid. Lambda, Ramp, Discord, and Strava remain materially more accessible.

Cocoanut Row Capital PartnersEndNext Steps
Close / Next Steps

The first prints validated the pipeline — and repriced the queue. The frontier labs have filed, the deferrals have declared themselves, and the work between now and the next issue is structure, transfer rights, and timing — the names, as ever, are knowable.

— Cocoanut Row Capital Partners · Pre-IPO Secondaries Desk · July 13, 2026
Visit cocoanutcapital.com ↗
Distribution & use: This briefing is research / sourcing context for internal desk use, not investment advice. Pricing levels cited are from secondary marketplaces (Forge Global, Hiive, Caplight, Nasdaq Private Market) and public aftermarket data, and reflect indicative marks rather than executable quotes. All valuations subject to last-round, secondary, or analyst-derived estimates and are point-in-time as of issue date.

Diligence: Recommend independent diligence on cap table, ROFR provisions, issuer transfer-approval policy, recent secondary clearing prices, and lock-up terms before any client commitment. Sources: SEC filings, Bloomberg, Reuters, CNBC, NPR, The Information, TechCrunch, Forge Global, Caplight, Kalshi, Polymarket, company press materials, and broker research.
Cocoanut Row Capital PartnersVol. 05 · 202617 / 17